概述
The Third Report of the Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol
in Adults (Adult Treatment Panel III, or ATP III)
presents the National Cholesterol Education Program’s
(NCEP’s) updated recommendations for cholesterol
testing and management. It is similar to Adult
Treatment Panel II (ATP II)1,2 in general outline and
fundamental approach to therapy. It focuses on the
role of the clinical approach to prevention of coronary
heart disease (CHD).* This report continues to identify
low-density lipoprotein (LDL) as the primary target of
cholesterol-lowering therapy. Since ATP II, a number
of controlled clinical trials with newer cholesterollowering
drugs have been reported. These trials
demonstrated remarkable reductions in risk for CHD,
in both primary and secondary prevention. Their
results enrich the evidence base upon which the new
guidelines are founded